Lowy as Acting NCI Director | GenomeWeb

Douglas Lowy has been named the acting director of the US National Cancer Institute, the National Institutes of Health has announced.

Lowy, who received the National Medal of Technology and Innovation in 2014 for his work that led to the development of the human papillomavirus vaccine, has served as the deputy director of the institute since July 2010.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Slow Report

New Models

Why So Few?

Biopsy Troubles

In PLOS this week: role for Notch signaling in congenital heart disease, sciatica risk variants, and more.

Researchers in China have used the CRISPR/Cas9 genome editing approach to alter the length of hair fibers in cashmere goats.

According to ScienceInsider, the Scripps Research Institute and the California Institute for Biomedical Research are merging.

National Cancer Institute researchers didn't report severe adverse events to Food and Drug Administration in a timely manner, the Wall Street Journal reports.